![Stephen Kennedy Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen Kennedy Smith
Nessuna posizione attualmente
Profilo
Stephen Kennedy Smith is the founder of Pear Therapeutics (US), Inc., which was founded in 2013.
He held the title of Executive Vice President-Corporate Development at Pear Therapeutics.
Mr. Smith also worked as a Director at Med-Design Corp.
In terms of education, he graduated from The Trustees of Columbia University in The City of New York, Harvard University, and Harvard Graduate School of Education.
Precedenti posizioni note di Stephen Kennedy Smith
Società | Posizione | Fine |
---|---|---|
Med-Design Corp. | Direttore/Membro del Consiglio | 07/06/2006 |
Pear Therapeutics (US), Inc.
![]() Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Fondatore | - |
Formazione di Stephen Kennedy Smith
Harvard University | Graduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Harvard Graduate School of Education | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Med-Design Corp. | Health Technology |
Pear Therapeutics (US), Inc.
![]() Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Technology Services |
- Borsa valori
- Insiders
- Stephen Kennedy Smith